Padagis US LLC drugs
12 results
Belladonna and opium (atropa belladonna and opium)
(ATROPA BELLADONNA and OPIUM)Padagis US LLC
Usage: Belladonna and opium suppositories are indicated for managing severe ureteral spasm pain that requires opioid analgesics when alternative treatments are inadequate. Due to risks of addiction and misuse, they should be reserved for patients who cannot tolerate or obtain relief from other options.
Brinzolamide (brinzolamide)
(brinzolamide)Padagis US LLC
Usage: Brinzolamide ophthalmic suspension is indicated for lowering elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.
Erythromycin (erythromycin)
(erythromycin)Padagis US LLC
Usage: Erythromycin is indicated for treating superficial ocular infections of the conjunctiva and/or cornea from susceptible organisms, and for prophylaxis against ophthalmia neonatorum caused by *N. gonorrhoeae* or *C. trachomatis*. It is not effective against penicillinase-producing *N. gonorrhoeae*.
Evamist (estradiol)
(Estradiol)Padagis US LLC
Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.
Ferrous gluconate (ferrous gluconate)
(FERROUS GLUCONATE)Padagis US LLC
Ferrous sulfate (ferrous sulfate)
(FERROUS SULFATE)Padagis US LLC
Flavoxate hydrochloride (flavoxate hydrochloride)
(FLAVOXATE HYDROCHLORIDE)Padagis US LLC
Usage: Flavoxate HCl tablets are indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency, and incontinence related to conditions like cystitis and prostatitis. They are not intended for definitive treatment but can be used alongside urinary tract infection medications.
Hydromorphone hydrochloride (hydromorphone hydrochloride)
(hydromorphone hydrochloride)Padagis US LLC
Usage: Hydromorphone hydrochloride extended-release tablets are indicated for managing severe, persistent pain requiring long-term opioid treatment when alternatives are inadequate. They are for opioid-tolerant patients only and are not intended for as-needed use due to risks of addiction and overdose.
Methylphenidate transdermal system (methylphenidate)
(methylphenidate)PADAGIS US LLC
Usage: Methylphenidate Transdermal System is indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients aged 6 to 17 years.
Podocon 25 (podophyllum resin)
(Podophyllum resin)Padagis US LLC
Usage: Podocon-25® (25% podophyllin in benzoin tincture) is indicated for the removal of soft genital warts (condylomata acuminata).